UK Devices Bill Offers Medtech An EU MDR Alternative – Or Better?
With the obvious distractions of coronavirus, the UK Medicines and Medical Devices bill has entered its second reading in parliament, accompanied by a drive for it to succeed from the government and opposition parties.
You may also be interested in...
Parliamentary committee meetings on the UK’s devices bill have been postponed as measures to tackle COVID-19 have been moved to center stage.
Osborne Clarke digital health lawyer Marcus Vass talks about the importance of digital, data and apps elements within the new UK Medicines and Medical Devices bill.
As the UK looks to its future healthtech regulatory model after Brexit, the ABHI’s regulatory director Phil Brown suggests a system whereby the same product data can be used as the basis for entry not only to the EU, but also to global markets.